What pharmacological groups of hepatoprotectors exist?

Pharmacological classification distinguishes several main groups based on their mechanism of action and origin. These include metabolic agents such as thioctic acid, as well as antioxidants including silybin. Essential phospholipids represent another significant group. Additionally, therapy utilizes lipotropic agents, amino acid-based agents stimulating ammonia detoxification, and other preparations such as royal jelly derivatives.

Which drugs belong to the essential phospholipids group?

Essential phospholipids include medications such as livolin and essentiale.

How does thioctic acid work?

It acts as a coenzyme for the oxidative decarboxylation of pyruvic and $\alpha$-keto acids, leading to improved energy metabolism in hepatocytes.

What is the primary objective of lipotropic agents?

Their main goal is the treatment and prevention of hepatic steatosis (fatty liver degeneration), which frequently occurs in alcoholism.

How do lipotropic drugs prevent fatty liver?

They correct choline deficiency, which is essential for phospholipid synthesis. This prevents the excessive deposition of neutral fat in cells.

Hepatoprotective Agents: Classes, Mechanism & USMLE Facts

Hepatoprotective Agents

Hepatoprotectores

For medical students2 min readUpdated 2026-10-10

Hepatoprotective agents are a group of medications designed to increase hepatocyte resistance to various damaging factors. A key property of these drugs is their ability to stimulate the recovery of lost or impaired liver cell functions.

Main goalProtection of liver cells and stimulation of their regeneration

MetabolismNormalization of energy metabolism in liver tissue

Treatment courseRequires prolonged use (averaging 45–60 days)

ProtectionPrevents neutral fat deposition in hepatocytes

Metabolic Agents

The key representative of this group is thioctic acid (also known as lipamide). The action of this drug is based on profound intervention in cellular metabolism.

Biochemical mechanism of action: Thioctic acid acts as a coenzyme in crucial oxidative decarboxylation reactions. Specifically, it participates in the metabolism of pyruvic acid and various $\alpha$-keto acids.

Through this biochemical process, the primary pharmacological effect is achieved—a significant improvement in energy metabolism directly within liver cells. In clinical practice, thioctic acid preparations are actively used in the complex treatment of liver cirrhosis. A specific feature of this therapy is the duration of the course, which typically ranges from 45 to 60 days to achieve a sustained therapeutic effect.

Antioxidants, Phospholipids, and Biogenic Preparations

In addition to metabolic agents, a wide range of drugs from other pharmacological groups is used to protect the liver, each with specific representatives:

Antioxidants: a classic representative is silybin, which neutralizes oxidative stress in tissues.
Essential phospholipids: include drugs such as livolin and essentiale, which serve as structural components of cell membranes.
Royal jelly-based preparations: for example, apilac, which acts as a natural biogenic stimulant.

Pharmacodynamics of these groups: The main objective of these agents is the reliable protection of hepatocytes against aggressive environmental and internal factors. Such damaging factors include:

Infectious agents.
Toxins of various origins (including the toxic effects of medications, alcohol, herbicides, and specific hepatotropic poisons).
Hypoxic states (tissue oxygen deprivation).
Radiation exposure.

Alongside their protective function, these drugs actively stimulate regenerative processes, helping the liver replenish its cellular pool faster.

Lipotropic Agents

Lipotropic agents represent a specialized group of hepatoprotectors. Their primary therapeutic goal is the treatment and prevention of hepatic steatosis (fatty liver disease). This pathology very frequently develops against the background of chronic alcoholism and can also accompany viral hepatitis, cholestasis, and liver cirrhosis.

Main representatives of the lipotropic series:

Methionine
Calcium pangamate
Choline chloride

Mechanism of action of lipotropic drugs: The therapeutic effect develops by correcting choline deficiency in the body. Choline is critical for phospholipid biosynthesis. By restoring normal phospholipid synthesis, lipotropic agents effectively prevent the pathological deposition of neutral fat in liver tissues, thereby halting the progression of fatty degeneration.

Mnemonic

To remember the main aggressive factors that hepatoprotectors protect against, use the mnemonic HITAR: Hypoxia, Infections, Toxins, Alcohol, Radiation.

Frequently asked questions

What pharmacological groups of hepatoprotectors exist?: Pharmacological classification distinguishes several main groups based on their mechanism of action and origin. These include metabolic agents such as thioctic acid, as well as antioxidants including silybin. Essential phospholipids represent another significant group. Additionally, therapy utilizes lipotropic agents, amino acid-based agents stimulating ammonia detoxification, and other preparations such as royal jelly derivatives.
Which drugs belong to the essential phospholipids group?: Essential phospholipids include medications such as livolin and essentiale.
How does thioctic acid work?: It acts as a coenzyme for the oxidative decarboxylation of pyruvic and $\alpha$-keto acids, leading to improved energy metabolism in hepatocytes.
What is the primary objective of lipotropic agents?: Their main goal is the treatment and prevention of hepatic steatosis (fatty liver degeneration), which frequently occurs in alcoholism.
How do lipotropic drugs prevent fatty liver?: They correct choline deficiency, which is essential for phospholipid synthesis. This prevents the excessive deposition of neutral fat in cells.

Go deeper

Biochemistry of oxidative decarboxylation
Phospholipid synthesis and the role of choline in the body
Pathogenesis of alcoholic hepatic steatosis
Mechanisms of antioxidant action on cell membranes